Skip to main content
OpenTrials

Clinical trial condition

Eye Abnormalities

Explore clinical trials studying Eye Abnormalities. Study availability and eligibility vary by location and protocol.

19 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Eye Abnormalities trial results

Completed

International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy

NCT04118738

Conditions
Arbovirus Infections, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +22 more
Locations
  • Departamento de Medicina Tropical da Universidade Federal de Pernambuco- UFPE Recife, Pernambuco, Brazil
  • Instituto Fernandes Figueira - FIOCRUZ Rio de Janeiro, Brazil
  • Centro Médico Imbanaco (CMI) Cali, Colombia
  • Asociación Civil Selva Amazónica Iquitos, Loreto, Peru
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

NCT03780257

Conditions
Abnormalities, Multiple, Blindness, Congenital Abnormalities, +27 more
Locations
  • Center for Clinical Research Operations, Massachusetts Eye and Ear Boston, Massachusetts, United States
  • University of Michigan, Kellogg Eye Center Ann Arbor, Michigan, United States
  • Casey Eye Institute, Oregon Health & Science University Portland, Oregon, United States
  • Retina Foundation of the Southwest Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

NCT06627179

Conditions
Abnormalities, Multiple, Blindness, Congenital Abnormalities, +28 more
Locations
  • The University of California, San Francisco San Francisco, California, United States
  • Bascom Palmer Eye Institute/University of Miami Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts Eye and Ear Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)

NCT03913143

Conditions
Blindness, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • Universitair Ziekenhuis Gent (UZ) Ghent, Belgium
  • INRET Clínica/ Santa Casa de Misericórdia de Belo Horizonte Belo Horizonte, Minas Gerais, Brazil
  • Federal University of São Paulo - Hospital São Paulo (UNIFESP-HSP) São Paulo, Brazil
View all 14 locations
View Trial Details

Related conditions